Urinary proteoglycan degradation product excretion in patients with rheumatoid arthritis and osteoarthritis.
AUTOR(ES)
Krajícková, J
RESUMO
The excretion of sugar components of glycosaminoglycans in the urine was investigated in 19 healthy controls, 27 patients with rheumatoid arthritis, and 24 with osteoarthritis. Both groups of patients excreted significantly more glucosamine, galactosamine, and mannose than the controls. The total uronic acid excretion, also, was higher in the two groups than in the healthy subjects. The possibility of using this method for the long term follow up of rheumatoid arthritis and osteoarthritis and the response to treatment is discussed.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1003547Documentos Relacionados
- Urinary and synovial pyridinium crosslink concentrations in patients with rheumatoid arthritis and osteoarthritis.
- Alterations in appendicular skeletal mass in patients with rheumatoid arthritis, psoriatic arthritis, and osteoarthritis.
- Cytokine expression in synovial membranes of patients with rheumatoid arthritis and osteoarthritis.
- Metabolic bone disease in rheumatoid arthritis and osteoarthritis.
- Urinary Excretion of Thiol Compounds in Patients with Rheumatoid Arthritis
